{"id":48828,"date":"2019-02-18T18:39:17","date_gmt":"2019-02-18T17:39:17","guid":{"rendered":"https:\/\/www.cfmot.de\/?p=48828"},"modified":"2019-02-18T18:40:38","modified_gmt":"2019-02-18T17:40:38","slug":"6-kooperationsforum-drug-development","status":"publish","type":"post","link":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/","title":{"rendered":"6. Kooperationsforum Drug Development"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"48828\" class=\"elementor elementor-48828 elementor-bc-flex-widget\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-886e220 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"886e220\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-093b2ca\" data-id=\"093b2ca\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c24fc48 elementor-widget elementor-widget-text-editor\" data-id=\"c24fc48\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>13. November 2013<\/strong><br \/><strong>Rudolf-Virchow-Zentrum<\/strong><br \/><strong>Universit\u00e4t W\u00fcrzburg<\/strong><\/p><p>\u00dcber das 6. Kooperationsforum Drug Development Targets \u2013 Design \u2013 Screening:<\/p><p>Die Bayern Innovativ konzipiert und organisiert als Koordinator des internationalen Netzwerkes Life Science das 6. Kooperationsforum &#8220;Drug Development&#8221; in enger Zusammenarbeit mit der Universit\u00e4t W\u00fcrzburg.<\/p><p><br \/><strong>Themenschwerpunkte sind:<\/strong><\/p><ul><li>Innovationen und Medical Need<\/li><li>GPCR Drug Targets<\/li><li>Strukturbasiertes Wirkstoffdesign<\/li><li>Drug-Target Interaktionen<\/li><li>Wirkstofftestung und Screening<\/li><\/ul><p>Ziel des Forums ist es, \u00fcber neuste Technologien und aktuelle Konzepte der Arzneimittelentwicklung zu informieren und neue Kontakte f\u00fcr zuk\u00fcnftige Kooperationen zu initiieren.<\/p><p>Experten aus der Pharma- und Biotech-Industrie sowie der Wissenschaft pr\u00e4sentieren Strategien zur Identifizierung neuer Drug Targets, neue Technologie-Plattformen und Testverfahren f\u00fcr die Wirkstoffentwicklung. Zugesagt haben bereits Referenten von Bayer HealthCare Pharmaceuticals, Novartis Pharma, Evotec, Morphosys, Intana Bioscience, Nanotemper Technologies, Dynamic Biosensors und wissenschaftlichen Instituten wie MPI f\u00fcr Molekulare Biomedizin, M\u00fcnster und IGB Fraunhofer-Projektgruppe Onkologie.<\/p><p>Die Cfm Oskar Tropitzsch nimmt an der begleitenden Fachausstellung teil und stellt Technologien, Produkte und Dienstleistungen im Bereich der Arzneimittelentwicklung vor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>13. November 2013 Rudolf-Virchow-Zentrum Universit\u00e4t W\u00fcrzburg \u00dcber das 6. Kooperationsforum Drug Development Targets \u2013 Design \u2013 Screening: Die Bayern Innovativ konzipiert und organisiert als Koordinator des internationalen Netzwerkes Life Science das 6. Kooperationsforum &#8220;Drug Development&#8221; in enger Zusammenarbeit mit der Universit\u00e4t W\u00fcrzburg. Themenschwerpunkte sind: Innovationen und Medical Need GPCR Drug Targets Strukturbasiertes Wirkstoffdesign Drug-Target Interaktionen [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":48831,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-48828","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>6. Kooperationsforum Drug Development - Cfm Oskar Tropitzsch GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"6. Kooperationsforum Drug Development - Cfm Oskar Tropitzsch GmbH\" \/>\n<meta property=\"og:description\" content=\"13. November 2013 Rudolf-Virchow-Zentrum Universit\u00e4t W\u00fcrzburg \u00dcber das 6. Kooperationsforum Drug Development Targets \u2013 Design \u2013 Screening: Die Bayern Innovativ konzipiert und organisiert als Koordinator des internationalen Netzwerkes Life Science das 6. Kooperationsforum &#8220;Drug Development&#8221; in enger Zusammenarbeit mit der Universit\u00e4t W\u00fcrzburg. Themenschwerpunkte sind: Innovationen und Medical Need GPCR Drug Targets Strukturbasiertes Wirkstoffdesign Drug-Target Interaktionen [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Cfm Oskar Tropitzsch GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-18T17:39:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-18T17:40:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cfmot.de\/wp-content\/uploads\/2019\/02\/drug_develop.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"520\" \/>\n\t<meta property=\"og:image:height\" content=\"175\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"4cfabian\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"4cfabian\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/\"},\"author\":{\"name\":\"4cfabian\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#\\\/schema\\\/person\\\/cfda3575aaaf36e88c60c988a3a319e8\"},\"headline\":\"6. Kooperationsforum Drug Development\",\"datePublished\":\"2019-02-18T17:39:17+00:00\",\"dateModified\":\"2019-02-18T17:40:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/\"},\"wordCount\":163,\"image\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/drug_develop.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/\",\"name\":\"6. Kooperationsforum Drug Development - Cfm Oskar Tropitzsch GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/drug_develop.jpg\",\"datePublished\":\"2019-02-18T17:39:17+00:00\",\"dateModified\":\"2019-02-18T17:40:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#\\\/schema\\\/person\\\/cfda3575aaaf36e88c60c988a3a319e8\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/drug_develop.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/drug_develop.jpg\",\"width\":520,\"height\":175,\"caption\":\"drug_develop\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/6-kooperationsforum-drug-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"6. Kooperationsforum Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/\",\"name\":\"Cfm Oskar Tropitzsch GmbH\",\"description\":\"Chemikalien, Feinchemikalien, Metallverbindungen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#\\\/schema\\\/person\\\/cfda3575aaaf36e88c60c988a3a319e8\",\"name\":\"4cfabian\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/author\\\/4cfabian\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"6. Kooperationsforum Drug Development - Cfm Oskar Tropitzsch GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"6. Kooperationsforum Drug Development - Cfm Oskar Tropitzsch GmbH","og_description":"13. November 2013 Rudolf-Virchow-Zentrum Universit\u00e4t W\u00fcrzburg \u00dcber das 6. Kooperationsforum Drug Development Targets \u2013 Design \u2013 Screening: Die Bayern Innovativ konzipiert und organisiert als Koordinator des internationalen Netzwerkes Life Science das 6. Kooperationsforum &#8220;Drug Development&#8221; in enger Zusammenarbeit mit der Universit\u00e4t W\u00fcrzburg. Themenschwerpunkte sind: Innovationen und Medical Need GPCR Drug Targets Strukturbasiertes Wirkstoffdesign Drug-Target Interaktionen [&hellip;]","og_url":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/","og_site_name":"Cfm Oskar Tropitzsch GmbH","article_published_time":"2019-02-18T17:39:17+00:00","article_modified_time":"2019-02-18T17:40:38+00:00","og_image":[{"width":520,"height":175,"url":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2019\/02\/drug_develop.jpg","type":"image\/jpeg"}],"author":"4cfabian","twitter_card":"summary_large_image","twitter_misc":{"Written by":"4cfabian","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#article","isPartOf":{"@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/"},"author":{"name":"4cfabian","@id":"https:\/\/www.cfmot.de\/en\/#\/schema\/person\/cfda3575aaaf36e88c60c988a3a319e8"},"headline":"6. Kooperationsforum Drug Development","datePublished":"2019-02-18T17:39:17+00:00","dateModified":"2019-02-18T17:40:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/"},"wordCount":163,"image":{"@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2019\/02\/drug_develop.jpg","articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/","url":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/","name":"6. Kooperationsforum Drug Development - Cfm Oskar Tropitzsch GmbH","isPartOf":{"@id":"https:\/\/www.cfmot.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2019\/02\/drug_develop.jpg","datePublished":"2019-02-18T17:39:17+00:00","dateModified":"2019-02-18T17:40:38+00:00","author":{"@id":"https:\/\/www.cfmot.de\/en\/#\/schema\/person\/cfda3575aaaf36e88c60c988a3a319e8"},"breadcrumb":{"@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#primaryimage","url":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2019\/02\/drug_develop.jpg","contentUrl":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2019\/02\/drug_develop.jpg","width":520,"height":175,"caption":"drug_develop"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cfmot.de\/en\/6-kooperationsforum-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cfmot.de\/en\/"},{"@type":"ListItem","position":2,"name":"6. Kooperationsforum Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/www.cfmot.de\/en\/#website","url":"https:\/\/www.cfmot.de\/en\/","name":"Cfm Oskar Tropitzsch GmbH","description":"Chemikalien, Feinchemikalien, Metallverbindungen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cfmot.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.cfmot.de\/en\/#\/schema\/person\/cfda3575aaaf36e88c60c988a3a319e8","name":"4cfabian","url":"https:\/\/www.cfmot.de\/en\/author\/4cfabian\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts\/48828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/comments?post=48828"}],"version-history":[{"count":3,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts\/48828\/revisions"}],"predecessor-version":[{"id":48833,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts\/48828\/revisions\/48833"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/media\/48831"}],"wp:attachment":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/media?parent=48828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/categories?post=48828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/tags?post=48828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}